Edition:
India

Amyris Inc (AMRS.OQ)

AMRS.OQ on NASDAQ Stock Exchange Global Select Market

5.88USD
22 Feb 2018
Change (% chg)

-- (--)
Prev Close
$5.88
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
64,349
52-wk High
$10.70
52-wk Low
$1.86

Chart for

About

Amyris, Inc. is an integrated industrial biotechnology company. The Company is engaged in research and development and sales of fuels and farnesene-derived products. It is applying its industrial synthetic biology platform to engineer, manufacture and sell products into a range of consumer and industrial markets, including... (more)

Overall

Beta: 0.07
Market Cap(Mil.): $127.11
Shares Outstanding(Mil.): 37.61
Dividend: --
Yield (%): --

Financials

BRIEF-DSM acquires Brazilian production facility from Amyris

* DSM expands strategic alliance with Amyris and acquires Brazilian production facility from Amyris

17 Nov 2017

BRIEF-Amyris posts Q3 GAAP loss of $1.14 per share

* Amyris reports another strong quarter of product sales growth and expects strong finish for 2017

15 Nov 2017

BRIEF-Amyris files for offering of up to 26.2 mln shares of common stock by selling stockholders‍​

* Amyris Inc files for offering of up to 26.2 million shares of common stock by the selling stockholders - SEC filing ‍​ Source text: (http://bit.ly/2zaU4Od) Further company coverage:

04 Nov 2017

BRIEF-Amyris Inc enters into agreement with Koninklijke DSM N.V.

* Amyris enters into product development and production agreement with Royal DSM for human nutrition ingredient

05 Oct 2017

BRIEF-Amyris enters into second major product development with Royal DSM

* Amyris Inc enters into second major product development and production agreement with Royal DSM

26 Sep 2017

Earnings vs. Estimates